An innovation in malaria eradication
for people and society
Homes should be a safe place to live.
Treating homes with VECTRON™ T500 will help prevent diseases
such a malaria and protect all who live there.
A home to grow our family and future.
Country Data
Burkina Faso
Experimental Hut Trial has been conducted in Burkina Faso to evaluate VECTRON™ T500 residual efficacy applied on both concrete and mud hut against pyrethroid susceptible Anopheles gambiae s.s. and resistant wild An. coluzzii. It provided residual efficacy (>80%) through nine months on concrete and mud substrates against susceptible, on mud substrate against resistant strain, for 8 months on concrete substrate against resistant strain.
Ghana
Village Hut Trial has been conducted in Ghana to evaluate VECTRON™ T500 residual efficacy applied on both concrete and mud hut against pyrethroid susceptible Anopheles gambiae s.s. and resistant wild An. gambiae s.l. It provided residual efficacy (>80%) through six months on cement and mud substrates. This trial will continue until 12 months after spraying.
Tanzania
Experimental Hut Trial has been conducted in Tanzania to evaluate VECTRON™ T500 residual efficacy applied on both concrete and mud hut against pyrethroid susceptible Anopheles gambiae s.s. and resistant An. gambiae s.s.Muleba-Kis. It provided residual efficacy (>80%) through seven months on concrete substrates and six months on mud. This trial will continue until 12 months after spraying.
Click on the country
- Registered
- Under development
What’s New
-
2023.04.21
VECTRON™ T500 is approved in Ghana
- 2023.04.18
-
2023.03.30
VECTRON™ T500 is approved in Rwanda
Product
VECTRON™ T500 is an innovative insecticide developed for
Indoor Residual Spraying (IRS) to support
insecticide resistance management (IRM) strategies.